Another defect found on a metal-on-metal hip replacement eventually leads to litigation against a manufacturer. An article about the risks of metal-on-metal hip replacement surgeries was earlier published on the New York Times.
As for Johnson & Johnson's case in particular, after information was out saying that the devices have defects in one out of eight clients, the ASR XL Acetabular System and the ASR Hip Resurfacing System were withdrawn. There are about 93,000 recipients of these products worldwide.
The Director of the National Joint Replacement Registry in Australia, Dr. Stephen Graves, says "It is a complete untruth that DePuy did not have reason to withdraw the ASR before now; we have been telling them since 2007, but they allowed it to be used on thousands of people."
"We believe we made the appropriate decision to recall at the appropriate time given the available information," states DePuy spokeswoman, Mindy Tinsley.
No comments:
Post a Comment